Reassess symptoms, physiologic status, and therapy response over time.

• Perform periodic reassessment for patients with HF risk, Stage B disease, or prior abnormal findings
• Evaluate for new or worsening symptoms at each clinical encounter
• Use objective reassessment to guide GDMT titration, diuretic strategy, and referral decisions
• Aim to prevent decompensation and reduce hospitalization risk through proactive monitoring